What Happens When You Stop Taking a GLP-1? Science Has an Uncomfortable Answer
It is the question almost everyone on a GLP-1 quietly searches at 2am: can I ever stop? Two randomized withdrawal trials, SURMOUNT-4 and STEP 1, have a clear and uncomfortable answer about what happens to the weight when the medication goes away.
It is the question almost everyone on a GLP-1 ends up typing into a search bar at 2am: can I ever stop?
The honest answer from the randomized trials is not the one most people are hoping for. But it is better to hear it clearly than to guess at it.
The short version
Two carefully run withdrawal trials asked exactly this — what happens when the drug goes away. Both landed in the same place: when you stop, a lot of the weight comes back, and it comes back fairly quickly. In the trials, staying on the medication was what kept the loss in place.
The tirzepatide trial: SURMOUNT-4
In SURMOUNT-4 (JAMA, 2024), 670 adults took tirzepatide for 36 weeks and lost an average of 20.9% of their body weight. Then, in a double-blind switch, half were moved onto a placebo for the next 52 weeks while the rest stayed on the drug.
Key point
Over that year, the group that kept taking tirzepatide lost another 5.5%. The group switched to placebo regained 14% — a gap of nearly 20 percentage points between staying on and coming off.
The semaglutide picture: STEP 1
STEP 1 (semaglutide) told a similar story. Participants lost about 14.9% of their weight over 68 weeks. In a follow-up that tracked them for a full year after everything stopped — the drug and the lifestyle program — they regained roughly two-thirds of what they had lost, about 11.6 percentage points, settling around 5.6% below where they started.
So people did not snap all the way back to baseline. But most of the loss did not hold on its own.
What actually separated the people who kept it off
Here is the uncomfortable part, stated plainly: in these trials, the thing that separated the maintainers from the regainers was continued medication — not willpower, not a particular diet. The researchers' own read is that, for many people, this is ongoing treatment, closer to how blood pressure is managed than to a short course of something.
One honest caveat: the trials stopped the lifestyle support at the same time as the drug, so they cannot tell us how much good habits alone would have carried. Separate weight-maintenance research — not these trials — points consistently to a few things worth building while you are on treatment:
- Protein and strength work, to protect muscle rather than just chase the number on the scale.
- Movement you will actually repeat, not a punishing program you abandon in a month.
- Staying tuned to your own food-noise and hunger cues, so a shift is something you catch early instead of months later.
Important
None of this is medical advice, and none of it is a reason to start, stop, or change a medication on your own. Whether and how to come off a GLP-1 is a conversation for you and your prescriber — full stop.
The bottom line
"Can I stop?" has a real answer, and it is not a comfortable one: for most people the weight tends to return without the medication, and the clearest predictor of keeping it off, in the trials, was staying on. That is not a verdict on you — it is information to bring to your doctor.
Tip
GLTrax check-ins make the early signs easy to see — logging protein, movement, and how loud the food noise is, week over week — so you and your prescriber are working from your real trend instead of a guess.
Sourcing note: Figures come from the published randomized trials — SURMOUNT-4 (Aronne et al., JAMA, 2024) for tirzepatide, and STEP 1 (Wilding et al., New England Journal of Medicine, 2021) with its one-year off-treatment extension (Diabetes, Obesity and Metabolism, 2022) for semaglutide.
One question for you: if staying on the medication long-term turned out to be part of your plan — not a failure to taper off, just the plan — what would "success" honestly look like for you?
This article is general education, not medical advice. Talk to your healthcare provider about your own treatment.